ZHANG MIQIN has a total of 12 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, medical technology and measurement are NANOTHERAPEUTICS INC, VAN EPPS DENNIS E and GREYSTONE MEDICAL GROUP INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Measurement | |
#4 | Textiles and paper | |
#5 | Biotechnology | |
#6 | Macromolecular chemistry and polymers |
# | Name | Total Patents |
---|---|---|
#1 | Zhang Miqin | 12 |
#2 | Bhattarai Narayan | 4 |
#3 | Sun Conroy | 2 |
#4 | Olson James M | 2 |
#5 | Veiseh Omid | 2 |
#6 | Ellenbogen Richard G | 2 |
#7 | Sze Raymond W | 1 |
#8 | Matsen Frederick A | 1 |
#9 | Park Steven I | 1 |
#10 | Florczyk Stephen | 1 |
Publication | Filing date | Title |
---|---|---|
US2013189367A1 | Nanovectors for targeted gene silencing and cytotoxic effect in cancer cells | |
US2012272347A1 | Chitosan-alginate scaffold cell culture system and related methods | |
US2012190049A1 | Glypican-3 targeting of liver cancer cells using multifunctional nanoparticles | |
WO2012058627A2 | Pre-targeted nanoparticle system and method for labeling biological particles | |
US2010234863A1 | Nanofibrous conduits for nerve regeneration | |
US2006251613A1 | Biodegradable chitosan-PEG compositions and methods of use |